PHI-501, a novel and potent pan-RAF inhibitor in metastatic melanoma

被引：0
|
作者：
Kim, Namkyeong
Park, Jung Hee
Nam, Ky-Youb
Han, June H-J
Kim, Kyu-Tae
Sengupta, Sandip
Yoon, Jeong Hyeok
Sim, Taebo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1627
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1627
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Anti-Tumor Effect of Pan-RAF Inhibitor in NSCLC Cells Harboring BRAF Mutation
    Miyauchi, S.
    Shien, K.
    Araki, K.
    Nakata, K.
    Miura, A.
    Namba, K.
    Suzawa, K.
    Yamamoto, H.
    Okazaki, M.
    Tomida, S.
    Toyooka, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S423 - S424
  • [32] Design, synthesis and evaluation of derivatives based on pyrimidine scaffold as potent Pan-Raf inhibitors to overcome resistance
    Wang, Lu
    Zhang, Qing
    Zhu, Gaoyuan
    Zhang, Zhimin
    Zhi, Yanle
    Zhang, Li
    Mao, Tianxiao
    Zhou, Xiang
    Chen, Yadong
    Lu, Tao
    Tang, Weifang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 130 : 86 - 106
  • [33] Identification of signal transduction kinases inhibited by pan-RAF inhibitor belvarafenib using FRET imaging technique
    Bae, Dong-Jun
    Kim, Sang-Yeob
    Byun, JooYun
    Bae, InHwan
    Ahn, YoungGil
    Kim, YoungHoon
    Suh, Kwee Hyun
    CANCER RESEARCH, 2019, 79 (13)
  • [34] Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor
    Huestis, Malcolm P.
    Dela Cruz, Darlene
    DiPasquale, Antonio G.
    Durk, Matthew R.
    Eigenbrot, Charles
    Gibbons, Paul
    Gobbi, Alberto
    Hunsaker, Thomas L.
    La, Hank
    Leung, Dennis H.
    Liu, Wendy
    Malek, Shiva
    Merchant, Mark
    Moffat, John G.
    Muli, Christine S.
    Orr, Christine J.
    Parr, Brendan T.
    Shanahan, Frances
    Sneeringer, Christopher J.
    Wang, Weiru
    Yen, Ivana
    Yin, Jianping
    Siu, Michael
    Rudolph, Joachim
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (05): : 791 - 797
  • [35] Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study.
    Kim, Tae Won
    Lee, Jeeyun
    Shin, Sang Joon
    Kim, Jin-Soo
    Kim, Yu Jung
    Han, Hye Sook
    Lee, Soo Jung
    Lim, Hyeong-Seok
    Hong, Yoon-hee
    Noh, Young Su
    Kyoung, Yujung
    Han, Oakpil
    Yoon, Jiyeon
    Lim, Jeong Ah
    Kim, Suk Ran
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] NOVEL PAN-RAF INHIBITOR BELVARAFENIB AS A PROMISING TARGETED THERAPY FOR BRAF-ALTERED PEDIATRIC LOW-GRADE GLIOMAS.
    Gonzalez, Maxine
    Lebert, Brittany
    Campion, Stephani
    Aguilar-Bonilla, Ana
    Smith, Amy
    NEURO-ONCOLOGY, 2023, 25
  • [37] Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity
    Abdel-Maksoud, Mohammed S.
    El-Gamal, Mohammed, I
    Lee, Bong S.
    El-Din, Mahmoud M. Gamal
    Jeon, Hong R.
    Kwon, Dow
    Ammar, Usama M.
    Mersal, Karim, I
    Ali, Eslam M. H.
    Lee, Kyung-Tae
    Yoo, Kyung Ho
    Han, Dong Keun
    Lee, Jae Kyun
    Kim, Garam
    Choi, Hong Seok
    Kwon, Young Jik
    Lee, Kwan Hyi
    Oh, Chang Hyun
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (10) : 6877 - 6901
  • [38] Drug drug interaction predictions for MLN2480, an investigational pan-RAF inhibitor, based on nonclinical data
    Balani, S. K.
    Bulychev, A.
    Cohen, L.
    Liao, M.
    Xia, C. Q.
    Wang, F.
    Li, P.
    LeClair, B.
    Bohnert, T.
    Gan, L.
    Zhou, X.
    Bozon, V.
    Prakash, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 54 - 55
  • [39] Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screeningDiscovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitorsA. Elkamhawy et al.
    Ahmed Elkamhawy
    Usama M. Ammar
    Minkyoung Kim
    Anam Rana Gul
    Tae Jung Park
    Kyeong Lee
    Archives of Pharmacal Research, 2025, 48 (2) : 150 - 165
  • [40] A Fluoro Derivative of Embelin, as Potent B-RAF Inhibitor in Melanoma
    Babu, Arunkumar
    Laila, Shiny P.
    Fernandez, Annette
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (15) : 2066 - 2074
12345